LncRNA VCAN‐AS1 Sponges miR‐374c‐3p to Promote Proliferation, Invasion, Migration, and EMT in Thyroid Cancer
International Journal of Endocrinology · 2026-01 · 2026 (1)
DOI: 10.1155/ije/8809262 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 06.03.2026. Verfasst von Yan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China, ujs.edu.cn. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Planning Social Development Project of Zhenjiang City.
Abstract (Originalsprache)
Background
Thyroid cancer (TC) is the most common endocrine malignancy worldwide, with a rising incidence in recent years. This study investigates the role of long noncoding RNA VCAN‐AS1 (lncRNA VCAN‐AS1) in TC cells and its underlying mechanism. Methods and Results LncRNA sequencing and RT‐qPCR revealed that VCAN‐AS1 expression in clinical TC tissues was significantly higher than in paracancerous tissues. Methods such as CCK‐8, cell scratching, Transwell, and Western Blot were employed to assess the impact of VCAN‐AS1 on TC cells. Overexpression of VCAN‐AS1 promoted TC cell proliferation, migration, and invasion; downregulated the epithelial‐mesenchymal transition (EMT)‐related protein E‐cadherin; and upregulated N‐cadherin, vimentin, slug, and snail. Conversely, silencing VCAN‐AS1 reversed these effects. Sequencing identified differentially expressed miR‐374c‐3p in TC cells between the control and VCAN‐AS1 overexpression groups, with functional analysis performed using GO and KEGG pathway enrichment. The regulation of miR‐374c‐3p by VCAN‐AS1 was detected by RT‐qPCR in TC cells, and dual‐luciferase assays confirmed the binding interaction between VCAN‐AS1 and miR‐374c‐3p. VCAN‐AS1 competitively binds with miR‐374c‐3p, and miR‐374c‐3p overexpression counteracts VCAN‐AS1‐induced oncogenic effects. In vivo experiments in mice confirmed the results obtained from in vitro experiments.
Conclusion
VCAN‐AS1 acts as a competing endogenous RNA, driving TC cell proliferation, migration, invasion, and EMT by sponging miR‐374c‐3p. These findings contribute to a novel theoretical basis for TC treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212000, China, ujs.edu.cn.
- Department of Endocrinology and Metabolism, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China, njmu.edu.cn.
- The First Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, 210029, China, njmu.edu.cn.
ORCID-Profile: Li Wang, Chenguang Wu
Förderung
- Science and Technology Planning Social Development Project of Zhenjiang City
Zitieren
APA
Zhang, Y., Sun, L., Wu, Y., Liu, Y., Jiang, H., Chen, X., Wang, L., & Wu, C. (2026). LncRNA VCAN‐AS1 Sponges miR‐374c‐3p to Promote Proliferation, Invasion, Migration, and EMT in Thyroid Cancer. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/8809262
Vancouver
Zhang Y, Sun L, Wu Y, Liu Y, Jiang H, Chen X, et al. LncRNA VCAN‐AS1 Sponges miR‐374c‐3p to Promote Proliferation, Invasion, Migration, and EMT in Thyroid Cancer. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/8809262
BibTeX
@article{Zhang2026,
author = {Zhang, Yan and Sun, Lu and Wu, Yuqi and Liu, Yingzhao and Jiang, Hui and Chen, Xiaoluo and Wang, Li and Wu, Chenguang},
title = {LncRNA VCAN‐AS1 Sponges miR‐374c‐3p to Promote Proliferation, Invasion, Migration, and EMT in Thyroid Cancer},
journal = {International Journal of Endocrinology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ije/8809262}
}
EUVIMED